<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02688153</url>
  </required_header>
  <id_info>
    <org_study_id>2011-11</org_study_id>
    <nct_id>NCT02688153</nct_id>
  </id_info>
  <brief_title>EDWARDS INTUITY Valve System CADENCE Study</brief_title>
  <acronym>CADENCE</acronym>
  <official_title>A Randomized Comparison of the EDWARDS INTUITY Valve System anD commErcially Available Aortic Bioprostheses in Subjects uNdergoing surgiCal Aortic Valve replacEment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to compare the EDWARDS INTUITY valve system with commercially available
      stented aortic bioprostheses, in patients requiring aortic valve replacement surgery with
      coronary artery bypass.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized study comparing the cross-clamp time (XCT) and cardiopulmonary bypass
      time (CPBT) of the EDWARDS INTUITY valve system with any commercially available stented
      aortic bioprosthesis, in patients with logistic EuroSCORE 1 ≥ 8 undergoing elective surgical
      aortic valve replacement surgery with concomitant coronary bypass grafts.

      Additionally, the aim is to gather sufficient data to quantify the effect size of short term
      patient benefit outcomes previously identified from literature and finally to explore
      additional healthcare resource utilization or health economic endpoints.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cross-clamp time</measure>
    <time_frame>At time of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiopulmonary bypass time</measure>
    <time_frame>At time of surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>NYHA (assessed during follow up)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-questionaire (6 questions)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Endpoints (Adverse Events observed after surgery)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gradients (mmHg)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VTI (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LVOT Diameter (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annulus size (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Septal thickness (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months ,6 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>EDWARDS INTUITY</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EDWARDS INTUITY Valve System, Model 8300A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stented aortic bioprostheses</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stented aortic bioprostheses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EDWARDS INTUITY</intervention_name>
    <description>To evaluate cardiac performance characteristics and adverse events rates associated with the EDWARDS INTUITY Valve in patients undergoing AVR &amp; CABG.</description>
    <arm_group_label>EDWARDS INTUITY</arm_group_label>
    <other_name>aortic stenosis</other_name>
    <other_name>stenosis-based insufficiency</other_name>
    <other_name>aortic valve replacement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stented aortic bioprostheses</intervention_name>
    <description>In comparison to control valves available on the market.</description>
    <arm_group_label>Stented aortic bioprostheses</arm_group_label>
    <other_name>aortic stenosis</other_name>
    <other_name>stenosis-based insufficiency</other_name>
    <other_name>aortic valve replacement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

          -  ≥18 years of age

          -  aortic stenosis / mixed aortic stenosis and aortic insufficiency

          -  SAVR+CABG (1-4 distal anastomoses)

          -  Log. EuroSCORE ≥6

          -  NYHA Class ≤II

        Exclusion (i.a.):

          -  pure aortic insufficiency

          -  pre-existing prosthetic heart valve or ring

          -  congenital true bicuspid / unicuspid aortic valve

          -  LVEF &lt;20%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Labrousse, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Bordeaux - Hôpital Haut-Lévèque</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Bordeaux, Hôpital Haut-Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2015</study_first_submitted>
  <study_first_submitted_qc>February 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2016</study_first_posted>
  <last_update_submitted>July 21, 2017</last_update_submitted>
  <last_update_submitted_qc>July 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Replacement</keyword>
  <keyword>Aortic Stenosis</keyword>
  <keyword>EDWARDS INTUITY</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 12, 2018</submitted>
    <returned>April 9, 2018</returned>
    <submitted>April 26, 2018</submitted>
    <returned>May 23, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

